| 19th Apr 2018 7:00 am |
RNS |
Breakthrough Research with Parsortix |
| 5th Apr 2018 7:00 am |
RNS |
First patient enrolled in FDA study |
| 26th Mar 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 26th Mar 2018 7:00 am |
RNS |
Research Update |
| 6th Feb 2018 7:00 am |
RNS |
ANGLE plc: RESEARCH GRANT FROM ABBOTT |
| 31st Jan 2018 7:00 am |
RNS |
Interim Results |
| 16th Jan 2018 7:00 am |
RNS |
WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCS |
| 10th Jan 2018 10:16 am |
RNS |
Notice of Results |
| 8th Jan 2018 7:00 am |
RNS |
ANGLE plc:Prostate cancer ARV7 treatment biomarker |
| 27th Dec 2017 11:49 am |
RNS |
Holding(s) in Company |
| 12th Dec 2017 7:00 am |
RNS |
Transfer of Lock-in Shares |
| 8th Dec 2017 7:00 am |
RNS |
PARSORTIX POTENTIAL IN METASTATIC BREAST CANCER |
| 28th Nov 2017 7:00 am |
RNS |
Parsortix enables CTC molecular characterisation |
| 23rd Nov 2017 7:00 am |
RNS |
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER |
| 17th Nov 2017 4:06 pm |
RNS |
Holding(s) in Company |
| 16th Nov 2017 8:23 am |
RNS |
Total Voting Rights and Covington Subscription |
| 6th Nov 2017 7:00 am |
RNS |
Holding(s) in Company |
| 6th Nov 2017 7:00 am |
RNS |
Holding(s) in Company |
| 6th Nov 2017 7:00 am |
RNS |
Holding(s) in Company |
| 2nd Nov 2017 10:04 am |
RNS |
Holding(s) in Company |
| 1st Nov 2017 8:12 am |
RNS |
ANGLE: Completion of Fundraising and Acquisition |
| 31st Oct 2017 2:18 pm |
RNS |
Result of AGM |
| 30th Oct 2017 10:31 am |
RNS |
Result of General Meeting |
| 26th Oct 2017 8:10 am |
RNS |
Total Voting Rights |
| 23rd Oct 2017 7:00 am |
RNS |
Parsortix harvests cancer cells from bone marrow |
| 20th Oct 2017 3:05 pm |
RNS |
Notice of AGM |
| 17th Oct 2017 7:00 am |
RNS |
ANGLE: 7th Peer Reviewed Publication On Parsortix |
| 12th Oct 2017 7:00 am |
RNS |
Proposed further subscription for £2.8 million |
| 9th Oct 2017 7:02 am |
RNS |
CTCs harvested with Parsortix grown in laboratory |
| 9th Oct 2017 7:01 am |
RNS |
Potential new analytical protocol using Parsortix |
| 9th Oct 2017 7:00 am |
RNS |
Parsortix Showcased at CTC Conference |
| 5th Oct 2017 11:46 am |
RNS |
Results of Fundraising |
| 5th Oct 2017 7:00 am |
RNS |
Acquisition and Fundraising |
| 13th Sep 2017 5:36 pm |
RNS |
Holding(s) in Company |
| 13th Sep 2017 7:00 am |
RNS |
Exclusive worldwide option over megakaryocyte IP |
| 11th Sep 2017 7:00 am |
RNS |
Co-Marketing Partnership with QIAGEN |
| 5th Sep 2017 7:00 am |
RNS |
Change of Adviser |
| 4th Sep 2017 7:00 am |
RNS |
New Research with Parsortix |
| 27th Jul 2017 7:00 am |
RNS |
Preliminary Results |
| 20th Jul 2017 1:00 pm |
RNS |
Preclinical Study Presented At Tumor Boston Summit |
